Skip to main content

Jobs Job Match Companies People Locations Salaries Blog Resume Scanner Post a Job

Zero G Talent

Jobs
Job Match
Companies
People
Locations
Salaries
Blog
Resume Scanner
Post a Job

About
Contact
Privacy
Terms

© 2026 Zero G Talent. All rights reserved.

Home
People
John Evans

John Evans

John Evans

CEO, DecisionCFO

Venture Partner at ARCH Venture Partners

New York, New York

About

Male

John Evans is the CEO of Beam Therapeutics. He attended The Wharton School.

Experience

ARCH Venture Partners

Venture Partner · 2017 – present

31Chicago, Illinois, United StatesFinance · Financial Services

CEO · Beam Therapeutics
2017 – present
CEO · DecisionCFO
2007 – present
Board Member · Beam Therapeutics
Advisor · Factr
Board Member · Prime Medicine

Education

Wharton School of the University of Pennsylvania · MBA, Healthcare Management
– 2005
University of Pennsylvania · MA, Biotechnology
– 2003
Yale University · BA, English
– 1999

ARCH Venture Partners Portfolio (1)

File SharingAcquired11 emp

People at ARCH Venture Partners

Principal, Chicago

Venture Partner

Data from: crunchbase

Carol Suh

Partner

Co-Founder and Managing Director

David Cruikshank

View all at ARCH Venture Partners →

Latest from John Evans

Headlines from Google News. Social posts load from the platform only when you open a tab.

Orbital Therapeutics Raises $270M to Bring RNA-Based Medicines to New Heights
MedCity News · Apr 26
Orbital Therapeutics Launches to Advance New Frontiers of Science with the Next Generation of Innovative RNA Medicines
Business Wire · Sep 7
Alnylam, Beam and More Launch New RNA Player Orbital Tx
BioSpace · Sep 7
Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing
PR Newswire · Jul 13
Beam Therapeutics Files for IPO, Pursuing Treatments Using Base Editing
Genetic Engineering and Biotechnology News · Sep 30